logo
close icon

Span Diagnostics awarded at ET-Now-IndiaMART Leaders of Tomorrow Awards 2011

Bio Spectrum,

Mr. Veeral Desai, Managing Director, Span Diagnostics, was one of the recipients of ‘ET NOW-IndiaMART Leaders of Tomorrow Awards 2011’ held in Mumbai recently. Mr. NR Narayana Murthy, Chairman Emeritus, Infosys Technologies, presented the award to the winner under pharmaceuticals and medical category and appreciated his contribution to fortify the MSME ecosystem with relentless efforts and creativity.

Outlining the importance of MSMEs and these awards, Mr. Dinesh Agarwal, Founder & CEO, IndiaMART.com, said, “These awards have been governed by the objective of defining leaders in the MSME space and recognizing their significance in the Indian economy. We are proud of Span Diagnostics for having emerged a leader of tomorrow and wish them best for robust business growth in future too. Their success would inspire the future MSME leaders and make these awards meaningful.”
After winning this award, Mr. Veeral Desai, said, “The award’s importance and value is symbolised by the selection process, and stature of the jury members. This award has brought sense of pride in each of our employee. It has enhanced our respect and image in society, which we could feel from the stream of messages pouring in from the different sections of society. We will be seen with more esteem by our vendors and customers now. This award has reinforced our faith in management philosophy and practices we follow and given us tremendous strength to pursue our goal with more vigor. It has increased our responsibility and accountability as a corporate citizen too.”

Ardently following the founder Dr. Pradip Desai’s ethical business practices and values, Mr. Veeral Desai expects the same from all his employees. He believes in strategic management processes that revolve around the main focus of the company – ‘Innovation and Creativity’. The company develops and manufactures a comprehensive range of indigenous ready-made diagnostic products needed by various segments of healthcare. Presently, it caters to an array of varied sections of diagnostics like Immunology, Biochemistry, Microbiology, Serology, Histopathology and instrumentation. To its humane side, the company does understand that many of the less privileged patients in India do not have access to proper and timely diagnostic solutions. Therefore, it continuously strives to make the company products affordable and improve access to all the needy underprivileged patients, wherever they dwell.

Latest Posts

IndiaMART InterMESH Limited closes the year with strong Q4FY25...

Posted on April 29, 2025

Increase in standalone revenue from operations at Rs. 336 Crore vs Rs. 299 Crore last year, driven by improvement in realization from paying suppliers The...

Read More

IndiaMART’s focus is to empower the small and medium...

Posted on April 29, 2025

  The B2B sector is expected to grow at 28% CAGR from 2021 to 2026, reaching $54 billion. This reflects the huge potential that still...

Read More

IndiaMART is supporting the growth of our business

Posted on April 29, 2025

Today, only 5% of MSMEs are fully digitized. With customers embracing technology in their daily lives, it has changed their buying habits and behavior. There...

Read More